Atrial natriuretic peptide for preventing and treating acute kidney injury

Nigwekar, Sagar U.; Navaneethan, Sankar D.; Parikh, Chirag R.; Hix, John K.

doi:10.1002/14651858.cd006028.pub2

Cited by 45 publications

(31 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, initial studies indicate that treatment options may become available to reverse AKI if promptly initiated [35]. Finally, early recognition of AKI might lead to a more timely involvement of the nephrology care team, which has been associated with improved patient outcome in intensive care unit patients developing acute renal failure [36].…”

Section: Discussionmentioning

confidence: 99%

Natriuretic peptides for early prediction of acute kidney injury in community-acquired pneumonia

Nowak

Breidthardt

Dejung

et al. 2013

Clinica Chimica Acta

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Natriuretic peptides for early prediction of acute kidney injury in community-acquired pneumonia

Nowak

Breidthardt

Dejung

et al. 2013

Clinica Chimica Acta

View full text Add to dashboard Cite

“…The incidence of complication by hypotension significantly increased (risk ratio: 1.69; 95% CI: 1.29‐ 2.22), but lower doses did not yield a significant association with hypotension (risk ratio: 1.25; 95% CI: 0.87–1.81). In addition, the AKI preventive effect obtained with low doses has been verified based primarily on cases of AKI occurring after heart surgery, and the results of another meta‐analysis281 also suggest the utility of ANP. However, the level of assessment with respect to sepsis cases remains insufficient.…”

Section: Cq12: Acute Kidney Injury/blood Apheresismentioning

confidence: 93%

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐SSCG2016)

Nishida

Ogura

Egi

et al. 2018

Acute Medicine & Surgery

157

View full text Add to dashboard Cite

Background and PurposeThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐SSCG 2016), a Japanese‐specific set of clinical practice guidelines for sepsis and septic shock created jointly by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, was first released in February 2017 in Japanese. An English‐language version of these guidelines was created based on the contents of the original Japanese‐language version.MethodsMembers of the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine were selected and organized into 19 committee members and 52 working group members. The guidelines were prepared in accordance with the Medical Information Network Distribution Service (Minds) creation procedures. The Academic Guidelines Promotion Team was organized to oversee and provide academic support to the respective activities allocated to each Guideline Creation Team. To improve quality assurance and workflow transparency, a mutual peer review system was established, and discussions within each team were open to the public. Public comments were collected once after the initial formulation of a clinical question (CQ), and twice during the review of the final draft. Recommendations were determined to have been adopted after obtaining support from a two‐thirds (>66.6%) majority vote of each of the 19 committee members.ResultsA total of 87 CQs were selected among 19 clinical areas, including pediatric topics and several other important areas not covered in the first edition of the Japanese guidelines (J‐SSCG 2012). The approval rate obtained through committee voting, in addition to ratings of the strengths of the recommendation and its supporting evidence were also added to each recommendation statement. We conducted meta‐analyses for 29 CQs. Thirty seven CQs contained recommendations in the form of an expert consensus due to insufficient evidence. No recommendations were provided for 5 CQs.ConclusionsBased on the evidence gathered, we were able to formulate Japanese‐specific clinical practice guidelines that are tailored to the Japanese context in a highly transparent manner. These guidelines can easily be used not only by specialists, but also by non‐specialists, general clinicians, nurses, pharmacists, clinical engineers, and other healthcare professionals.

show abstract

“…Most of the prospective randomized controlled trials and 3 meta-analyses have not found any benefit associated with these agents [185][186][187][188].…”

Section: Rationalementioning

confidence: 99%

Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)

Ichai

Vinsonneau

Souweine

et al. 2016

Anaesthesia Critical Care & Pain Medicine

View full text Add to dashboard Cite

Acute kidney injury (AKI) is a syndrome that has progressed a great deal over the last 20 years. The decrease in urine output and the increase in classical renal biomarkers, such as blood urea nitrogen and serum creatinine, have largely been used as surrogate markers for decreased glomerular filtration rate (GFR), which defines AKI. However, using such markers of GFR as criteria for diagnosing AKI has several limits including the difficult diagnosis of non-organic AKI, also called "functional renal insufficiency" or "pre-renal insufficiency". This situation is characterized by an oliguria and an increase in creatininemia as a consequence of a reduction in renal blood flow related to systemic haemodynamic abnormalities. In this situation, "renal insufficiency" seems rather inappropriate as kidney function is not impaired. On the contrary, the kidney delivers an appropriate response aiming to recover optimal systemic physiological haemodynamic conditions. Considering the kidney as insufficient is erroneous because this suggests that it does not work correctly, whereas the opposite is occurring, because the kidney is healthy even in a threatening situation. With current definitions of AKI, normalization of volaemia is needed before defining AKI in order to avoid this pitfall.

show abstract

Atrial natriuretic peptide for preventing and treating acute kidney injury

Cited by 45 publications

References 58 publications

Natriuretic peptides for early prediction of acute kidney injury in community-acquired pneumonia

Natriuretic peptides for early prediction of acute kidney injury in community-acquired pneumonia

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐SSCG2016)

Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)

Contact Info

Product

Resources

About